Cite

HARVARD Citation

    Siddiqi, Z. et al. (2021). Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study. Muscle & nerve. 64 (6), pp. 662-669. [Online]. 
  
Back to record